whitepaper Brochure: Biologics workflow solutions brochure 10 November 2021 | By PerkinElmer Biologics solutions from discovery to manufacturing.
news Soluble fibrinogen a potential target for neurodegeneration 9 November 2021 | By Anna Begley (Drug Target Review) In a pre-clinical study, fibrinogen increased the death of mouse brain neurons, suggeting fibrin can have similar toxic effects on neurons.
news $9 million grant awarded to uncover whether Parkinson’s starts in the nose 29 October 2021 | By Anna Begley (Drug Target Review) A new grant will allow an international team to determine if scent-processing nerves in the nose play a role in the development of Parkinson's and could aid in the development of novel therapeutics.
news Scientists target ALS and dementia RNA using novel molecule 28 October 2021 | By Anna Begley (Drug Target Review) The small molecule successfully targeted the C9orf72 gene that causes amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
webinar Capturing biological complexity to empower biomarker discovery 27 October 2021 | By Takara Bio Sign up for this free webinar and discover how refined cell atlases can provide comprehensive roadmaps for health and disease.
whitepaper Whitepaper: Phenotypic and functional CAR-T cell characterisation 25 October 2021 | By Sartorius AG This whitepaper overviews phenotypic and functional characterisation of CAR-T cells with advanced flow cytometry and live-cell analysis.
news CRISPR screening tool exposes new leukaemia drug target 29 September 2021 | By Anna Begley (Drug Target Review) A CRISPR screening tool identified a new target for acute myeloid leukaemia with fewer side effects than current approaches.
news “Ultrasensitive” HPV detection paves way for precision treatment 28 September 2021 | By Anna Begley (Drug Target Review) A new study sequenced tumour DNA for the “ultrasensitive” detection of HPV, further honing precision treatment of the illness.
news DNA methylation could determine liver disease progression 21 September 2021 | By Anna Begley (Drug Target Review) DNA methylation at specific genomic sites was found to correlate with non-fatty liver disease and could be used to diagnose severity.
news Club cell factors may reverse immune suppression in tumours 21 September 2021 | By Anna Begley (Drug Target Review) New research has revealed that club cells secret anti-immunosuppressive factors in tumours, potentially revolutionising cancer therapies.
news Gut microbiome linked to rheumatoid arthritis prognosis 15 September 2021 | By Anna Begley (Drug Target Review) New genomic study reveals that the microbiome could predict rheumatoid arthritis prognosis, potentially advancing treatments.
news New Gut Cell Atlas reveals genetic origins of Crohn’s disease 10 September 2021 | By Anna Begley (Drug Target Review) The Gut Cell Atlas comprises 428,000 cells in the gut and sheds light on the origin of Crohn’s disease and other intestinal diseases.
news Artificial intelligence could revolutionise glycomics datasets 9 September 2021 | By Anna Begley (Drug Target Review) Researchers have created a tool that allows glycomics datasets to be analysed using artificial intelligence for early cancer diagnoses.
video On-demand webinar: An AI-based approach to phenotypic characterisation of neuronal cells 26 August 2021 | By Molecular Devices Evaluation of neurotoxicity effects is an active area of investigation in drug discovery and disease modeling.
news Cartilage growth gene TRPV4 shows promise for joint repair therapy 26 August 2021 | By Anna Begley (Drug Target Review) The discovery that the TRPV4 gene regulates cartilage growth could lead to treatments for osteoarthritis and other cartilage diseases.
